The effect of restrictive bariatric surgery on urolithiasis

Journal of Endourology

Volumn 27, Issue 2, 2013, Pages 242-244

  Chen, Tony ^a   Godebu, Elana ^b   Horgan, Santiago ^b   Mirheydar, Hossein S ^b   Sur, Roger L ^b,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO HEALTH SYSTEM   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BARIATRIC SURGERY; FEMALE; FOLLOW UP; GASTRIC BANDING; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEPHROLITHIASIS; OBESITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SLEEVE GASTRECTOMY; TREATMENT DURATION; TREATMENT OUTCOME; UROLITHIASIS;

BARIATRIC SURGERY; FEMALE; GASTRECTOMY; HUMANS; LAPAROSCOPY; MALE; UROLITHIASIS;

EID: 84873092181     PISSN: 08927790     EISSN: 1557900X     Source Type: Journal    
DOI: 10.1089/end.2012.0408     Document Type: Article

References (14)

1. Malnick SD, Knobler H. The medical complications of obesity. QJM 2006;99:565-579.
2. Wang YC, McPherson K, Marsh T, et al. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 2011;378:815-825.
3. Sturm R. Increases in morbid obesity in the USA: 2000-2005. Public Health 2007;121:492-496.
4. Picot J, Jones J, Colquitt JL, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: A systematic review and economic evaluation. Health Technol Assess 2009;13:1-190, 215-357, iii-iv.
5. Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683-2693.
6. Smith BR, Schauer P, and Nguyen NT. Surgical approaches to the treatment of obesity: Bariatric surgery. Med Clin North Am 2011;95:1009-1030.
7. Nelson WK, Houghton SG, Milliner DS, et al. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: Potentially serious and unappreciated complications of Roux-en-Y gastric bypass. Surg Obes Relat Dis 2005;1:481-485.
8. Kumar R, Lieske JC, Collazo-Clavell ML, et al. Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery. Surgery 2011;149:654-661.
9. Matlaga BR, Shore AD, Magnuson T, et al. Effect of gastric bypass surgery on kidney stone disease. J Urol 2009;181:2573-2577.
10. Semins MJ, Asplin JR, Steele K, et al. The effect of restrictive bariatric surgery on urinary stone risk factors. Urology 2010;76:826-829.
11. Semins MJ, Matlaga BR, Shore AD, et al. The effect of gastric banding on kidney stone disease. Urology 2009;74:746-749.
12. Gordis L. Epidemiology. 4th ed. Philadelphia: Elsevier, 2009, pp 39-40.
13. Tice JA, Karliner L, Walsh J, et al. Gastric banding or bypass? A systematic review comparing the two most popular bar-iatric procedures. Am J Med 2008;121:885-893.
14. Nadler EP, Youn HA, Ren CJ, Fielding GA. An update on 73 US obese pediatric patients treated with laparoscopic adjustable gastric banding: Comorbidity resolution and compliance data. J Pediatr Surg 2008;43:141-146.